Scarica l'app Stockscreener
46.61
4.31%
-2.10
Anaptysbio Inc Azioni (ANAB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
76.39%
25.56
|
108.25 | 76.32 | 22.26 | 27.77 |
| Operating Expenses |
45.58%
60.19
|
41.35 | 41.62 | 48.43 | 55.31 |
| Operating Income/Loss |
151.77%
-34.64
|
66.90 | 34.70 | -26.17 | -27.54 |
| Nonoperating Income/Loss |
5.82%
-18.21
|
-17.21 | -19.59 | -12.42 | -11.75 |
| Income/Loss From Continuing Operations Before Tax |
206.34%
-52.84
|
49.70 | 15.11 | -38.59 | -39.28 |
| Income Tax Expense/Benefit, Current |
0.04
|
- | - | - | 0.044 |
| Income Tax Expense/Benefit |
50.62%
0.04
|
0.081 | - | 0.039 | 0.044 |
| Net Income/Loss |
206.59%
-52.88
|
49.61 | 15.11 | -38.63 | -39.33 |
| Basic Average Shares |
8,874%
28.69
|
-0.327 | 27.83 | 28.81 | 30.64 |
| Diluted Average Shares |
8,874%
28.69
|
-0.327 | 29.02 | 28.81 | 30.64 |
| Basic Earnings Per Share |
208.24%
-1.84
|
1.70 | 0.54 | -1.34 | -1.28 |
| Diluted Earnings Per Share |
208.24%
-1.84
|
1.70 | 0.52 | -1.34 | -1.28 |
7.53%
4.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):